Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 3,250.00
-69.40 (-2.09%)
Sep 5, 2025, 3:29 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 271.38 billion as of September 5, 2025. Its market cap has decreased by -2.51% in one year.
Market Cap
271.38B
Enterprise Value
261.65B
Revenue
25.29B
Ranking
n/a
PE Ratio
52.85
Stock Price
3,250.00
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 271.38B, an increase of 298.02%. That is a compound annual growth rate of 15.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 271.38B | 8.55% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | 190.13B | 54.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,823.58B |
| Divi's Laboratories | 1,628.25B |
| Cipla | 1,254.77B |
| Apollo Hospitals Enterprise | 1,122.17B |
| Mankind Pharma | 1,052.78B |
| Zydus Lifesciences | 1,020.17B |
| Fortis Healthcare | 715.59B |
| Alkem Laboratories | 637.70B |